CPRX - CATALYST PHARMACEUTICALS, INC.
24.32
-0.370 -1.521%
Share volume: 1,731,335
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$24.69
-0.37
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-06-2024 | 02-26-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | 02-25-2026 | |
| Assets | |||||||||
| Total Assets | 646.676 M | 706.360 M | 772.010 M | 851.411 M | 908.872 M | 971.915 M | 1.052 B | 1.104 B | |
| Current Assets | 404.602 M | 474.429 M | 538.998 M | 623.609 M | 685.718 M | 758.739 M | 852.453 M | 894.030 M | |
| Inventories | 19.953 M | 18.014 M | 20.017 M | 19.541 M | 19.778 M | 18.650 M | 28.029 M | 37.166 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 310.411 M | 375.693 M | 442.331 M | 517.553 M | 580.656 M | 652.800 M | 689.892 M | 709.171 M | |
| Total Non-current Assets | 15.345 M | 13.083 M | 14.842 M | 21.564 M | 24.208 M | 21.256 M | 19.167 M | 22.536 M | |
| Property Plant Equipment | 1.308 M | 1.227 M | 1.380 M | 1.354 M | 1.239 M | 1.149 M | 1.077 M | 1.037 M | |
| Other Assets | 240.766 M | 230.704 M | 231.632 M | 226.448 M | 221.915 M | 212.027 M | 198.072 M | 208.912 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 646.676 M | 706.360 M | 772.010 M | 851.411 M | 908.872 M | 971.915 M | 1.052 B | 1.104 B | |
| Total liabilities | 85.264 M | 97.705 M | 111.069 M | 123.779 M | 114.589 M | 115.888 M | 131.357 M | 149.711 M | |
| Total current liabilities | 79.566 M | 92.318 M | 105.395 M | 120.678 M | 111.649 M | 113.007 M | 128.735 M | 147.152 M | |
| Accounts Payable | 10.261 M | 7.116 M | 11.563 M | 16.593 M | 11.197 M | 5.528 M | 9.096 M | 11.202 M | |
| Other liabilities | 5.698 M | 5.387 M | 5.674 M | 3.101 M | 2.940 M | 2.881 M | 2.622 M | 2.559 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 5.698 M | 5.387 M | 5.674 M | 3.101 M | 2.940 M | 2.881 M | 2.622 M | 2.559 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 561.412 M | 608.655 M | 660.941 M | 727.632 M | 794.283 M | 856.027 M | 920.245 M | 954.268 M | |
| Common stock | 416.865 M | 423.314 M | 431.716 M | 442.407 M | 452.402 M | 461.990 M | 473.456 M | 480.080 M | |
| Retained earnings | 144.547 M | 185.341 M | 229.225 M | 285.161 M | 341.898 M | 394.006 M | 446.789 M | 474.188 M |